Navigation Links
Criterion™ II Urine Analyzer

ProductsCriterion™ II Urine Analyzer
Company Roche Diagnostics
Item Criterion™ II Urine Analyzer
Features Easy to use:
  • User-friendly operation - simply dip and insert the urine test strip
  • Save time with automatic transmission of results to host PC after each measurement
  • Flexible entry of sample ID with numeric keypad or optional bar code reader

    • Risk-free color interpretation:
  • Ensure consistency of results with automatic color measurement
  • Programmable setup options include three, four, or five color determinations

    • Reduce false negative results and the need to retest:
  • Virtually eliminates vitamin C interference for blood and glucose
  • CHEMSTRIP technology consistently measures both acetoacetic acid and acetone

    • Minimal calibration and maintenance requirements:
  • Calibration required only once every 14 days
  • Daily maintenance takes less than one minutes with two simple steps
  • Simply remove waste tray and discard strips
  • Rinse with cleaning solution, then rinse with tap water
    • Description An easy-to-operate, semi-automatic urine analyzer that ensures accurate results, test after test. It maximizes your lab efficiency by reducing "hands on" operator time. And its convenient, compact design makes it an ideal fit for work areas large or small.

    The Chemstrip Criterion II Analyzer is designed for continuous sample processing of Chemstrip 10 MD Urine Test Strips from Roche Diagnostics. It is optimized for 15-75 tests per day

    Accurate urinalysis screening begins with a quality test strip. The patented construction of the Chemstrip Urine Test Strip includes absorbent pads underlying the reagent pad held in place by a mesh laminate overlay, rather than adhesive. This facilitates absorbency and rapid diffusion of the sample, prevents chemical runover onto adjacent strips, and provides easy-to-read, uniform, distinct color changes.
    Info Roche DiagnosticsCall Roche Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-415-6694

    Customer Service: 1-800-428-5074
    Web site: http://www.roche-diagnostics.com

    Related medicine products :

    1. Clinitek 500 Urine Chemistry Analyzer
    2. Clinitek Atlas Automated Urine Chemistry Analyzer (Rack)
    3. Chemstrip 101 Urine Analyzer
    4. Clinitek Atlas Automated Urine Chemistry Analyzer (Carousel)
    5. Urisys 1100 Urine Analyzer
    6. DiaScreen 50 Urine Chemistry Analyzer
    7. FSH Home Menopause Test Midstream (Urine)
    8. FSH Home Menopause Test Device (Urine)
    9. Acon One Step Ovulation Test Device (Urine)
    10. One Step LH Urine Ovulation Test
    11. URS-1K Urine Ketone Test Strip
    ...y™ Elbow and Hand Spasticity Orthosis decrea...tremity post-stroke. Treat elbow, forearm, wrist s... patient and adjust to meet available passive ROM....mponent. Then apply hand cone to the bar. Use incl...
    ...Elbow Cryo/Cuff combines the therapeutic benefits ... and swelling, and cold to minimize pain. The cuff...bow providing maximum cryotherapy. The Elbow Cryo/...a pediatric size.,All Cryo/Cuffs can be ordered as...
    ...FoamWrap ACTION Elbow Wrap replaces messy taping a... and others experiencing epicondylitis. Preferred ...d non-bulky fit. Two overlay straps allow you to a... lining holds the Elbow Wrap comfortably in place....
    ...contour design of this lightweight brace allows it...lizes the ankle joint following severe sprains, te...piral stays move with the ankle and provide optimu... splint control rotational strains on the ankle, a...
    Medicine Products:
    (Date:7/25/2008)...ormer McKesson Corporation Executive, Robert J. Re...ewswire/ -- Aethon Inc.,( http://www.aethon.com ),...ital supply chain logistics, today announced that ...Vice President -- Chief Financial Officer., Reill... Manager for,McKesson Corporation,s Specialty Phar...
    (Date:7/25/2008)... HOUSTON, July 25 /PRNewswire/ -- The Elekta Fami... cancer treatment solutions at the 2008,American A... meeting,demonstrating how the joint forces of El...diation therapy planning and delivery solutions th...tter experience for,patients, as well as enhance c...
    (Date:7/25/2008)... CARLSBAD, Calif., July 25 /PRNewswire/ -- AutoGe...egistration statement on Form S-1 with the,Securit...ed initial public,offering of shares of its common... offered, all of which are expected to be offered ... offering, have not yet been,determined., J.P. Mo...
    (Date:7/25/2008)...turday can be toughest for those trying to drop po...ealthDay News) -- Anyone who has avoided Monday mo...ends are not a dieter,s friend. , Now, research...ts about weekends being their undoing: Most people...ing to lose weight. , "Weekend indulgences can ...
    Breaking Medicine News(10 mins):Health News:Aethon, Inc. Names New Chief Financial Officer 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:Weekends Tough on the Diet 2Health News:Weekends Tough on the Diet 3
    ...established in the near future for those suffering...DS //. Health Minister Mary Harney said that he ...on of a Bill to address insurance difficulties fac...e diseases while administering blood and blood pro...
    ... Council is seeking various opinions on the issue ...ips with former patients //without fear of a ban. ...d to be extremely careful and remind them that the... be considered inappropriate. In a move that nul...
    ...epressant that had been linked to heart abnormalit...German researchers told a European fertility confe... found no increased risk and that women might have...ncies fearing that the drug could affect their bab...
    ...ed three doctors of the Indraprastha Apollo Hospit...d information //on the condition of Rahul Mahajan,...tion of suspected drug overdose. "We have summone...n," said Suman Nalwa, assistant commissioner of po...
    Other Medicine News:Health News:Police Summoned Apollo Doctors in Rahul Mahajan’s Cas 2
    (Date:7/23/2008)...- Sound Pharmaceuticals (SPI) has filed,an Investi... clinical,testing of a proprietary formulation of ... hearing loss or ototoxicity. The oral capsule,con...ced stage lung cancer,and head and neck cancer pat...marks the second development program for SPI to en...
    (Date:7/23/2008)...rstCall/ -- Dendreon Corporation,(Nasdaq: DNDN ) ...ta,Monitoring Committee (IDMC) to review in Octobe...lating to the Company,s Phase 3 IMPACT (IMmunother...own as D9902B) clinical trial,of PROVENGE(R) (sipu...al,active cellular immunotherapy for the treatment...
    (Date:7/22/2008)...s Development Initiative bring MJFF,s,current acti...nuary 20,2009, NEW YORK, July 22 /PRNewswire-USN...ry of transformative treatments and a cure for Par...r Parkinson,s Research has awarded,$2.7 million in... awards,were granted under MJFF,s Therapeutics Dev...
    (Date:7/22/2008)...he Importance to Patients of Passing a ...OND, Va., July 22 /- Insmed...iologics and biopharmaceuticals, today,announced t...sent at a,Congressional briefing on Friday, July 2...blishing an approval pathway for follow-on,biologi...
    Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Transdel Initiates Ketotransdel 28TM 29 Phase 3 Clinical Program for Pain 2434 1Transdel Initiates Ketotransdel 28TM 29 Phase 3 Clinical Program for Pain 2434 2Transdel Initiates Ketotransdel 28TM 29 Phase 3 Clinical Program for Pain 2434 3Transdel Initiates Ketotransdel 28TM 29 Phase 3 Clinical Program for Pain 2434 4Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin 28formerly SNS 595 29 in Patients with Acute Myeloid Leukemia at the 13th Con 2431 1Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin 28formerly SNS 595 29 in Patients with Acute Myeloid Leukemia at the 13th Con 2431 2Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin 28formerly SNS 595 29 in Patients with Acute Myeloid Leukemia at the 13th Con 2431 3Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin 28formerly SNS 595 29 in Patients with Acute Myeloid Leukemia at the 13th Con 2431 4Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin 28formerly SNS 595 29 in Patients with Acute Myeloid Leukemia at the 13th Con 2431 5Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin 28formerly SNS 595 29 in Patients with Acute Myeloid Leukemia at the 13th Con 2431 6Cardiva Medical Inc to Present at the Investment In Innovation 28In3 29 Medical Device Summit on June 18 2008 in San Francisco CA 3B Announces th 21891 1Cardiva Medical Inc to Present at the Investment In Innovation 28In3 29 Medical Device Summit on June 18 2008 in San Francisco CA 3B Announces th 21891 2PAREXEL Experts to Address Key Industry Topics at the Drug Information Association 44th Annual Meeting 5997 1PAREXEL Experts to Address Key Industry Topics at the Drug Information Association 44th Annual Meeting 5997 2PAREXEL Experts to Address Key Industry Topics at the Drug Information Association 44th Annual Meeting 5997 3PAREXEL Experts to Address Key Industry Topics at the Drug Information Association 44th Annual Meeting 5997 4PAREXEL Experts to Address Key Industry Topics at the Drug Information Association 44th Annual Meeting 5997 5PAREXEL Experts to Address Key Industry Topics at the Drug Information Association 44th Annual Meeting 5997 6PAREXEL Experts to Address Key Industry Topics at the Drug Information Association 44th Annual Meeting 5997 7
    ...NA, Calif.--(BUSINESS WIRE)--Jun 1, 2007 - Arrowhe...day that interim Phase I data,has been published i...Proceedings (ASCO) (Abstract ID 32638). The data a... to evaluate the safety,tolerability, and pharmac...IT-101, in patients with inoperable or metastatic,...
    ... SAN FRANCISCO, Calif., June 01, 2007,/PRNewswire-...announced that the company will present data from ... the 12th Congress of the European,Hematology Asso...,Austria. , Presentations will include updated in...al of SNS-595 in acute leukemias, as,well as clini...
    Other Medicine Technology:Arrowhead Subsidiary, Insert, Publishes Interim Phase I Data from,Human Clinical Trials for New Cancer Drug 2Arrowhead Subsidiary, Insert, Publishes Interim Phase I Data from,Human Clinical Trials for New Cancer Drug 3Sunesis Pharmaceuticals to Present Data at the 12th Congress of the,European Hematology Association 2Sunesis Pharmaceuticals to Present Data at the 12th Congress of the,European Hematology Association 3